Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscle, Skeletal | 17 | 2024 | 4901 | 1.740 |
Why?
|
Muscular Diseases | 3 | 2023 | 551 | 1.680 |
Why?
|
Regeneration | 8 | 2023 | 1505 | 1.560 |
Why?
|
Satellite Cells, Skeletal Muscle | 3 | 2023 | 126 | 1.140 |
Why?
|
Teichoic Acids | 1 | 2024 | 70 | 0.920 |
Why?
|
Musculoskeletal Physiological Phenomena | 1 | 2023 | 30 | 0.890 |
Why?
|
Burns | 10 | 2018 | 1849 | 0.860 |
Why?
|
Rhytidoplasty | 1 | 2024 | 68 | 0.860 |
Why?
|
Tissue Scaffolds | 5 | 2023 | 925 | 0.800 |
Why?
|
Mammaplasty | 6 | 2023 | 1241 | 0.780 |
Why?
|
Muscle Development | 6 | 2020 | 259 | 0.750 |
Why?
|
Sarcopenia | 3 | 2023 | 372 | 0.740 |
Why?
|
Mastectomy | 4 | 2023 | 1834 | 0.730 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2020 | 37 | 0.730 |
Why?
|
Skin Transplantation | 5 | 2018 | 1083 | 0.710 |
Why?
|
Contracture | 3 | 2024 | 235 | 0.710 |
Why?
|
Surgical Wound Infection | 3 | 2018 | 1521 | 0.680 |
Why?
|
Fibrosis | 6 | 2023 | 2038 | 0.680 |
Why?
|
Guided Tissue Regeneration | 1 | 2019 | 87 | 0.650 |
Why?
|
Aortic Aneurysm, Abdominal | 8 | 2006 | 1215 | 0.630 |
Why?
|
Occlusive Dressings | 1 | 2018 | 52 | 0.620 |
Why?
|
Quadriceps Muscle | 1 | 2019 | 154 | 0.610 |
Why?
|
Surgical Flaps | 7 | 2023 | 1669 | 0.600 |
Why?
|
Breast Implantation | 2 | 2017 | 222 | 0.580 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2023 | 1926 | 0.570 |
Why?
|
Chitosan | 1 | 2018 | 130 | 0.560 |
Why?
|
Matrix Metalloproteinase 9 | 7 | 2006 | 632 | 0.550 |
Why?
|
Lipopolysaccharides | 1 | 2024 | 2203 | 0.540 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2023 | 3480 | 0.520 |
Why?
|
Matrix Metalloproteinase 2 | 4 | 2006 | 461 | 0.500 |
Why?
|
Wound Healing | 5 | 2021 | 2781 | 0.490 |
Why?
|
Facial Transplantation | 4 | 2021 | 221 | 0.470 |
Why?
|
Parabiosis | 1 | 2014 | 64 | 0.470 |
Why?
|
Pancreatic Elastase | 6 | 2006 | 128 | 0.410 |
Why?
|
Immunity, Innate | 2 | 2024 | 3043 | 0.410 |
Why?
|
Cartoons as Topic | 1 | 2011 | 15 | 0.390 |
Why?
|
Osteosarcoma | 1 | 2016 | 896 | 0.350 |
Why?
|
Recovery of Function | 2 | 2019 | 2969 | 0.330 |
Why?
|
Aging | 6 | 2023 | 8654 | 0.330 |
Why?
|
Glycosaminoglycans | 2 | 2023 | 605 | 0.320 |
Why?
|
Animals | 38 | 2024 | 167718 | 0.310 |
Why?
|
Tissue Engineering | 4 | 2023 | 1868 | 0.290 |
Why?
|
Cell Cycle | 1 | 2016 | 2929 | 0.290 |
Why?
|
Breast Implants | 2 | 2024 | 410 | 0.290 |
Why?
|
Child Welfare | 1 | 2011 | 515 | 0.280 |
Why?
|
Muscle Fibers, Skeletal | 5 | 2018 | 540 | 0.270 |
Why?
|
Rats, Sprague-Dawley | 9 | 2023 | 8143 | 0.270 |
Why?
|
Gene Expression Profiling | 4 | 2020 | 9403 | 0.260 |
Why?
|
Breast | 1 | 2015 | 1961 | 0.260 |
Why?
|
Nitroso Compounds | 1 | 2006 | 71 | 0.260 |
Why?
|
Testosterone | 2 | 2014 | 2465 | 0.260 |
Why?
|
Nitric Oxide Donors | 1 | 2006 | 124 | 0.260 |
Why?
|
Facial Injuries | 2 | 2017 | 190 | 0.250 |
Why?
|
Mice | 21 | 2024 | 81066 | 0.250 |
Why?
|
Health Education | 1 | 2011 | 1049 | 0.240 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2006 | 1170 | 0.240 |
Why?
|
Postoperative Complications | 4 | 2024 | 15532 | 0.230 |
Why?
|
Muscular Atrophy | 2 | 2024 | 327 | 0.230 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2023 | 747 | 0.230 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 592 | 0.230 |
Why?
|
Muscle Strength | 2 | 2019 | 618 | 0.230 |
Why?
|
Adipose Tissue | 1 | 2016 | 3298 | 0.230 |
Why?
|
Cell Movement | 4 | 2018 | 5196 | 0.230 |
Why?
|
Bone Neoplasms | 1 | 2016 | 2524 | 0.220 |
Why?
|
Cell Proliferation | 2 | 2017 | 10405 | 0.220 |
Why?
|
Collagen | 2 | 2023 | 2634 | 0.220 |
Why?
|
Rats | 11 | 2023 | 23676 | 0.210 |
Why?
|
Organ Size | 3 | 2019 | 2248 | 0.210 |
Why?
|
Rejuvenation | 1 | 2024 | 106 | 0.210 |
Why?
|
Metalloendopeptidases | 1 | 2004 | 393 | 0.210 |
Why?
|
NF-kappa B | 2 | 2024 | 2472 | 0.200 |
Why?
|
Porosity | 1 | 2023 | 348 | 0.200 |
Why?
|
Mice, Inbred C57BL | 7 | 2023 | 21990 | 0.200 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 367 | 0.200 |
Why?
|
Surgery, Plastic | 3 | 2016 | 643 | 0.190 |
Why?
|
India | 5 | 2016 | 2328 | 0.190 |
Why?
|
Estrogen Receptor beta | 1 | 2022 | 168 | 0.190 |
Why?
|
Breast Neoplasms | 7 | 2023 | 20992 | 0.190 |
Why?
|
Cicatrix | 2 | 2024 | 780 | 0.180 |
Why?
|
Wounds and Injuries | 3 | 2021 | 2475 | 0.170 |
Why?
|
Signal Transduction | 6 | 2024 | 23335 | 0.160 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2006 | 695 | 0.160 |
Why?
|
Physical Therapy Modalities | 1 | 2023 | 536 | 0.160 |
Why?
|
Health Promotion | 1 | 2011 | 2201 | 0.160 |
Why?
|
Hematoma | 1 | 2024 | 768 | 0.160 |
Why?
|
Skin Pigmentation | 1 | 2021 | 276 | 0.160 |
Why?
|
Neuromuscular Junction | 1 | 2021 | 403 | 0.160 |
Why?
|
Leukocytes | 1 | 2006 | 2024 | 0.160 |
Why?
|
Ischemic Preconditioning | 1 | 2018 | 89 | 0.150 |
Why?
|
Estrogen Receptor alpha | 1 | 2022 | 580 | 0.150 |
Why?
|
Replantation | 1 | 2018 | 145 | 0.140 |
Why?
|
Lymphedema | 1 | 2023 | 526 | 0.140 |
Why?
|
Rectus Abdominis | 2 | 2023 | 102 | 0.140 |
Why?
|
Fetus | 2 | 2014 | 1860 | 0.130 |
Why?
|
Keratinocytes | 2 | 2018 | 790 | 0.130 |
Why?
|
Thyroid Hormone Receptors alpha | 1 | 2016 | 13 | 0.130 |
Why?
|
Sex Characteristics | 1 | 2006 | 2621 | 0.130 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2016 | 60 | 0.130 |
Why?
|
Pentylenetetrazole | 1 | 2016 | 71 | 0.130 |
Why?
|
Nutritional Requirements | 1 | 2017 | 275 | 0.130 |
Why?
|
Oxidative Stress | 1 | 2006 | 3102 | 0.130 |
Why?
|
Transplantation, Homologous | 4 | 2021 | 4808 | 0.120 |
Why?
|
Humans | 42 | 2024 | 757566 | 0.120 |
Why?
|
rho-Associated Kinases | 1 | 2016 | 280 | 0.120 |
Why?
|
Aorta, Abdominal | 3 | 2006 | 625 | 0.120 |
Why?
|
Organ Preservation | 1 | 2018 | 379 | 0.120 |
Why?
|
Hypertrophy | 2 | 2014 | 555 | 0.120 |
Why?
|
Time Factors | 6 | 2018 | 39811 | 0.120 |
Why?
|
Disease Models, Animal | 7 | 2018 | 18114 | 0.120 |
Why?
|
Graft Survival | 4 | 2018 | 3794 | 0.120 |
Why?
|
Transplantation, Autologous | 2 | 2018 | 2113 | 0.120 |
Why?
|
Stem Cells | 3 | 2023 | 3521 | 0.110 |
Why?
|
Diseases in Twins | 1 | 2015 | 447 | 0.110 |
Why?
|
Female | 26 | 2024 | 389943 | 0.110 |
Why?
|
Neutrophil Infiltration | 2 | 2006 | 387 | 0.110 |
Why?
|
Wrist Injuries | 1 | 2015 | 214 | 0.110 |
Why?
|
Bronchodilator Agents | 1 | 2016 | 505 | 0.110 |
Why?
|
Apoptosis | 3 | 2022 | 9466 | 0.110 |
Why?
|
Thyroid Hormones | 1 | 2016 | 404 | 0.110 |
Why?
|
Hand Injuries | 1 | 2015 | 239 | 0.110 |
Why?
|
Treatment Outcome | 9 | 2024 | 64242 | 0.100 |
Why?
|
Extremities | 1 | 2018 | 865 | 0.100 |
Why?
|
Gene Expression Regulation | 4 | 2016 | 11890 | 0.100 |
Why?
|
Kerosene | 1 | 2012 | 15 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1087 | 0.100 |
Why?
|
Graft Rejection | 3 | 2021 | 4427 | 0.100 |
Why?
|
Cells, Cultured | 9 | 2018 | 18936 | 0.100 |
Why?
|
Enzyme Activation | 3 | 2009 | 3593 | 0.100 |
Why?
|
Mitochondria | 1 | 2005 | 3583 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2020 | 1402 | 0.100 |
Why?
|
Gene Expression | 3 | 2021 | 7584 | 0.100 |
Why?
|
West Virginia | 1 | 2011 | 31 | 0.100 |
Why?
|
Mice, Knockout | 3 | 2024 | 14345 | 0.100 |
Why?
|
Postoperative Care | 1 | 2018 | 1468 | 0.100 |
Why?
|
Cytokines | 1 | 2006 | 7336 | 0.100 |
Why?
|
Male | 24 | 2023 | 358180 | 0.100 |
Why?
|
Anti-Asthmatic Agents | 1 | 2016 | 565 | 0.100 |
Why?
|
Enteral Nutrition | 1 | 2017 | 786 | 0.100 |
Why?
|
Thoracic Wall | 1 | 2013 | 199 | 0.090 |
Why?
|
Alternative Splicing | 1 | 2016 | 1091 | 0.090 |
Why?
|
Hypothyroidism | 1 | 2016 | 665 | 0.090 |
Why?
|
Osteogenesis | 2 | 2014 | 1271 | 0.090 |
Why?
|
Perfusion | 3 | 2018 | 1374 | 0.090 |
Why?
|
Workload | 1 | 2016 | 845 | 0.090 |
Why?
|
Fibroblasts | 2 | 2018 | 4087 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2443 | 0.090 |
Why?
|
Irritants | 1 | 2009 | 43 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2018 | 2903 | 0.080 |
Why?
|
Perioperative Care | 1 | 2017 | 1023 | 0.080 |
Why?
|
Dioxoles | 1 | 2009 | 95 | 0.080 |
Why?
|
Receptors, Notch | 1 | 2014 | 743 | 0.080 |
Why?
|
Tetrahydroisoquinolines | 1 | 2009 | 81 | 0.080 |
Why?
|
Cell Line | 2 | 2020 | 15587 | 0.080 |
Why?
|
Embryonic Stem Cells | 1 | 2016 | 1262 | 0.080 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2006 | 1486 | 0.080 |
Why?
|
Myostatin | 1 | 2009 | 126 | 0.080 |
Why?
|
Memory Disorders | 1 | 2016 | 1198 | 0.080 |
Why?
|
Skin Ulcer | 1 | 2009 | 129 | 0.080 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 441 | 0.070 |
Why?
|
Epigastric Arteries | 2 | 2023 | 92 | 0.070 |
Why?
|
Soft Tissue Injuries | 1 | 2009 | 171 | 0.070 |
Why?
|
Earthquakes | 1 | 2010 | 186 | 0.070 |
Why?
|
Pilot Projects | 2 | 2018 | 8550 | 0.070 |
Why?
|
Myocytes, Cardiac | 1 | 2016 | 1655 | 0.070 |
Why?
|
Child, Preschool | 6 | 2020 | 42045 | 0.070 |
Why?
|
Patient Preference | 1 | 2015 | 917 | 0.070 |
Why?
|
Reading | 1 | 2011 | 529 | 0.070 |
Why?
|
International Cooperation | 2 | 2011 | 1428 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 1 | 2018 | 1631 | 0.070 |
Why?
|
Immunohistochemistry | 5 | 2014 | 11063 | 0.070 |
Why?
|
Cyclic N-Oxides | 1 | 2006 | 72 | 0.070 |
Why?
|
Cell Differentiation | 3 | 2020 | 11469 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1651 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2022 | 3774 | 0.070 |
Why?
|
Burn Units | 2 | 2017 | 141 | 0.070 |
Why?
|
Bariatric Surgery | 1 | 2015 | 986 | 0.060 |
Why?
|
Leiomyosarcoma | 1 | 2009 | 423 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2016 | 2867 | 0.060 |
Why?
|
Caspase 9 | 1 | 2005 | 185 | 0.060 |
Why?
|
Spin Labels | 1 | 2006 | 336 | 0.060 |
Why?
|
Matrix Metalloproteinases, Membrane-Associated | 1 | 2004 | 14 | 0.060 |
Why?
|
Logistic Models | 2 | 2017 | 13221 | 0.060 |
Why?
|
Emergency Medical Services | 1 | 2016 | 1915 | 0.060 |
Why?
|
Developing Countries | 3 | 2012 | 2865 | 0.060 |
Why?
|
Catalase | 1 | 2005 | 216 | 0.060 |
Why?
|
Organ Culture Techniques | 1 | 2006 | 794 | 0.060 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2005 | 132 | 0.060 |
Why?
|
Dilatation, Pathologic | 1 | 2006 | 527 | 0.060 |
Why?
|
Disasters | 1 | 2010 | 517 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8503 | 0.060 |
Why?
|
P-Selectin | 1 | 2006 | 597 | 0.060 |
Why?
|
RNA, Messenger | 4 | 2006 | 12761 | 0.060 |
Why?
|
Adolescent | 6 | 2020 | 87819 | 0.060 |
Why?
|
Patient Satisfaction | 3 | 2013 | 3440 | 0.060 |
Why?
|
Young Adult | 5 | 2017 | 58755 | 0.060 |
Why?
|
Adult | 10 | 2018 | 219725 | 0.060 |
Why?
|
Hydrogen Peroxide | 1 | 2006 | 728 | 0.050 |
Why?
|
Caspase 3 | 1 | 2005 | 728 | 0.050 |
Why?
|
Antigens, Ly | 1 | 2024 | 292 | 0.050 |
Why?
|
Reoperation | 3 | 2021 | 4279 | 0.050 |
Why?
|
Caspases | 1 | 2005 | 876 | 0.050 |
Why?
|
Schools | 1 | 2011 | 1482 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2007 | 1133 | 0.050 |
Why?
|
Drug Implants | 2 | 2018 | 230 | 0.050 |
Why?
|
Child | 6 | 2020 | 79782 | 0.050 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2558 | 0.050 |
Why?
|
Fat Necrosis | 2 | 2013 | 60 | 0.050 |
Why?
|
Aortic Aneurysm | 1 | 2006 | 648 | 0.050 |
Why?
|
DNA Methylation | 1 | 2015 | 4372 | 0.050 |
Why?
|
Injury Severity Score | 2 | 2017 | 1032 | 0.050 |
Why?
|
Students | 1 | 2011 | 1729 | 0.050 |
Why?
|
Staining and Labeling | 1 | 2005 | 1083 | 0.050 |
Why?
|
Adipogenesis | 2 | 2014 | 358 | 0.050 |
Why?
|
Cell Adhesion | 1 | 2007 | 3087 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39020 | 0.050 |
Why?
|
Interleukin-1beta | 1 | 2006 | 995 | 0.050 |
Why?
|
PPAR gamma | 1 | 2023 | 481 | 0.050 |
Why?
|
Up-Regulation | 2 | 2006 | 4110 | 0.040 |
Why?
|
Necrosis | 2 | 2018 | 1604 | 0.040 |
Why?
|
Tamoxifen | 1 | 2005 | 964 | 0.040 |
Why?
|
Neutropenia | 1 | 2005 | 884 | 0.040 |
Why?
|
Aged | 6 | 2021 | 167890 | 0.040 |
Why?
|
Inflammation | 2 | 2018 | 10709 | 0.040 |
Why?
|
Transfection | 2 | 2018 | 5777 | 0.040 |
Why?
|
Swine | 2 | 2021 | 5891 | 0.040 |
Why?
|
Middle Aged | 7 | 2018 | 219192 | 0.040 |
Why?
|
Registries | 1 | 2015 | 8164 | 0.040 |
Why?
|
Estrogens | 2 | 2022 | 1519 | 0.040 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2021 | 278 | 0.040 |
Why?
|
Antioxidants | 1 | 2006 | 1665 | 0.040 |
Why?
|
Neovascularization, Physiologic | 2 | 2021 | 1332 | 0.040 |
Why?
|
Down-Regulation | 1 | 2006 | 2901 | 0.040 |
Why?
|
Ink | 1 | 2018 | 47 | 0.040 |
Why?
|
Mice, Obese | 1 | 2018 | 420 | 0.040 |
Why?
|
Protein Isoforms | 2 | 2016 | 1694 | 0.040 |
Why?
|
Asthma | 1 | 2016 | 6172 | 0.040 |
Why?
|
Suction | 1 | 2018 | 263 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 29488 | 0.040 |
Why?
|
Tissue Expansion | 1 | 2018 | 160 | 0.040 |
Why?
|
Cohort Studies | 2 | 2018 | 41190 | 0.040 |
Why?
|
Sodium Salicylate | 1 | 2016 | 18 | 0.040 |
Why?
|
Skin Physiological Phenomena | 1 | 2018 | 188 | 0.040 |
Why?
|
Paracrine Communication | 1 | 2018 | 276 | 0.040 |
Why?
|
Anniversaries and Special Events | 1 | 2017 | 94 | 0.030 |
Why?
|
Biliopancreatic Diversion | 1 | 2015 | 15 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2018 | 1758 | 0.030 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2016 | 107 | 0.030 |
Why?
|
Internship and Residency | 1 | 2016 | 5854 | 0.030 |
Why?
|
France | 1 | 2017 | 497 | 0.030 |
Why?
|
Receptors, Steroid | 1 | 2016 | 156 | 0.030 |
Why?
|
Program Development | 2 | 2013 | 1296 | 0.030 |
Why?
|
Esthetics | 1 | 2017 | 326 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2018 | 12078 | 0.030 |
Why?
|
Platelet-Rich Plasma | 1 | 2018 | 178 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3257 | 0.030 |
Why?
|
Stem Cell Transplantation | 2 | 2014 | 1598 | 0.030 |
Why?
|
CA1 Region, Hippocampal | 1 | 2016 | 110 | 0.030 |
Why?
|
Body Surface Area | 1 | 2015 | 197 | 0.030 |
Why?
|
Needs Assessment | 2 | 2012 | 1138 | 0.030 |
Why?
|
Estradiol | 1 | 2022 | 1933 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2007 | 3526 | 0.030 |
Why?
|
Cell Lineage | 2 | 2014 | 2532 | 0.030 |
Why?
|
Cold Temperature | 1 | 2018 | 780 | 0.030 |
Why?
|
Macrophages | 2 | 2006 | 5732 | 0.030 |
Why?
|
Oxidative Phosphorylation | 1 | 2016 | 495 | 0.030 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2016 | 368 | 0.030 |
Why?
|
Infant | 4 | 2020 | 36045 | 0.030 |
Why?
|
Protein Stability | 1 | 2016 | 568 | 0.030 |
Why?
|
Time | 1 | 2016 | 543 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2018 | 1841 | 0.030 |
Why?
|
PAX7 Transcription Factor | 1 | 2014 | 55 | 0.030 |
Why?
|
Long-Term Potentiation | 1 | 2016 | 293 | 0.030 |
Why?
|
Dendritic Spines | 1 | 2016 | 243 | 0.030 |
Why?
|
Trauma Severity Indices | 1 | 2015 | 478 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1806 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 2014 | 351 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2017 | 58558 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 10749 | 0.030 |
Why?
|
Integrin alpha Chains | 1 | 2014 | 95 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2016 | 9514 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2016 | 1153 | 0.030 |
Why?
|
Pyramidal Cells | 1 | 2016 | 368 | 0.030 |
Why?
|
Stem Cell Niche | 1 | 2016 | 345 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2742 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2014 | 5861 | 0.030 |
Why?
|
Efficiency | 1 | 2016 | 476 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2016 | 1164 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2023 | 79984 | 0.030 |
Why?
|
Sweden | 1 | 2015 | 1376 | 0.030 |
Why?
|
Neutrophils | 1 | 2005 | 3756 | 0.030 |
Why?
|
Hydrogels | 1 | 2018 | 722 | 0.030 |
Why?
|
Patient Selection | 2 | 2017 | 4235 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2018 | 1110 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2017 | 2496 | 0.030 |
Why?
|
Heart Failure | 1 | 2016 | 11595 | 0.030 |
Why?
|
Work Schedule Tolerance | 1 | 2016 | 551 | 0.020 |
Why?
|
Homozygote | 1 | 2016 | 1788 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 21986 | 0.020 |
Why?
|
Burns, Chemical | 1 | 2012 | 122 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1664 | 0.020 |
Why?
|
Exons | 1 | 2016 | 2392 | 0.020 |
Why?
|
Risk Factors | 1 | 2017 | 73708 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2016 | 1168 | 0.020 |
Why?
|
Hernia, Abdominal | 1 | 2010 | 56 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2637 | 0.020 |
Why?
|
Donor Selection | 1 | 2011 | 227 | 0.020 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2009 | 101 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2014 | 1870 | 0.020 |
Why?
|
Haiti | 1 | 2010 | 550 | 0.020 |
Why?
|
DNA Damage | 1 | 2018 | 2439 | 0.020 |
Why?
|
Cell Separation | 1 | 2014 | 1720 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1895 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2006 | 22022 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2834 | 0.020 |
Why?
|
Risk Assessment | 3 | 2017 | 23816 | 0.020 |
Why?
|
Leptin | 1 | 2015 | 1590 | 0.020 |
Why?
|
Incidence | 2 | 2017 | 21217 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1740 | 0.020 |
Why?
|
Metabolomics | 1 | 2016 | 1629 | 0.020 |
Why?
|
Aorta | 2 | 2005 | 2037 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5781 | 0.020 |
Why?
|
Surgical Mesh | 1 | 2010 | 310 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2267 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6292 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3757 | 0.020 |
Why?
|
Glucose | 1 | 2018 | 4336 | 0.020 |
Why?
|
Military Personnel | 1 | 2015 | 1240 | 0.020 |
Why?
|
Dimerization | 1 | 2007 | 888 | 0.020 |
Why?
|
Cricetulus | 1 | 2007 | 815 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2016 | 26176 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2495 | 0.020 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2009 | 617 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2022 | 16881 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2014 | 2378 | 0.020 |
Why?
|
Matrix Metalloproteinase 8 | 1 | 2005 | 56 | 0.020 |
Why?
|
Amitrole | 1 | 2005 | 8 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 151 | 0.020 |
Why?
|
CHO Cells | 1 | 2007 | 1389 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2847 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5778 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2012 | 1825 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 2212 | 0.010 |
Why?
|
Critical Care | 1 | 2017 | 2690 | 0.010 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 527 | 0.010 |
Why?
|
Device Removal | 1 | 2009 | 629 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4159 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2010 | 967 | 0.010 |
Why?
|
Skin | 1 | 2018 | 4464 | 0.010 |
Why?
|
Cricetinae | 1 | 2007 | 2427 | 0.010 |
Why?
|
Echocardiography | 1 | 2016 | 4963 | 0.010 |
Why?
|
Drainage | 1 | 2009 | 1155 | 0.010 |
Why?
|
Physician's Role | 1 | 2010 | 916 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 2005 | 602 | 0.010 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2005 | 288 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 3996 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9298 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4407 | 0.010 |
Why?
|
Dogs | 1 | 2007 | 3838 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3602 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2006 | 20499 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2007 | 2674 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6956 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2015 | 3732 | 0.010 |
Why?
|
Low Back Pain | 1 | 2010 | 979 | 0.010 |
Why?
|
Retinal Vessels | 1 | 2007 | 836 | 0.010 |
Why?
|
Protein Transport | 1 | 2007 | 1963 | 0.010 |
Why?
|
Length of Stay | 1 | 2015 | 6384 | 0.010 |
Why?
|
Cost of Illness | 1 | 2011 | 1925 | 0.010 |
Why?
|
Sex Factors | 2 | 2005 | 10495 | 0.010 |
Why?
|
Cell Communication | 1 | 2007 | 1650 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 5638 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18326 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13263 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 2011 | 1903 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16533 | 0.010 |
Why?
|
Health Policy | 1 | 2011 | 2674 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4565 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7796 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 5031 | 0.010 |
Why?
|
Protein Binding | 1 | 2007 | 9312 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17767 | 0.010 |
Why?
|
Pregnancy | 1 | 2015 | 29712 | 0.010 |
Why?
|
Obesity | 1 | 2015 | 12870 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2011 | 5382 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15781 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 54092 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 29929 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 25924 | 0.010 |
Why?
|